NCT02891876 (CPDB) is a clinical trial in Dental Pulp Capping, sponsored by University Hospital, Brest.

Who is sponsoring NCT02891876?

NCT02891876 is sponsored by University Hospital, Brest.

What condition does NCT02891876 study?

NCT02891876 studies Dental Pulp Capping.

Is NCT02891876 still recruiting?

NCT02891876 is currently completed. Last updated 29 November 2017.

Last reviewed 2017-11-29 · How we verify

NCT02891876: CPDB

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

3-months Success Rate of Direct Pulp Capping With Biodentine®

Completed Last updated 29 November 2017

What this trial tests

trial in Dental Pulp Capping in 40 participants. Completed in 2 December 2016.

Timeline

27 May 2015

Primary endpoint
2 December 2016

2 December 2016

Quick facts

Lead sponsor	University Hospital, Brest
Status	Completed
Study type	OBSERVATIONAL
Enrollment	40
Start date	27 May 2015
Primary completion	2 December 2016
Estimated completion	2 December 2016
Sites	1 location across France

Conditions studied

Dental Pulp Capping — all drugs for Dental Pulp Capping →

Sponsor

University Hospital, Brest

Who can join

Adults 18 to 40, any sex, with Dental Pulp Capping. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Biodentine® is a most recent material for direct pulp capping. The aim of this study is to determine the 3 months success rate (defined as clinical and radiographic successes together) of direct pulp capping realized with Biodentine®.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Brest trials

Trials by the same sponsor.

NCT07526688 — Aerobic Physical Activity and Orofacial Myofascial Pain · NA · not yet recruiting
NCT07487155 — Unified Junction of Care, Integrated Treatments and Team Coordination for ADHD in Prison Settings With Substance Use Dis · NA · not yet recruiting
NCT07417605 — Diagnostic Performance Of 4D Dynamic LAFOV FDG-PET Acquisition for Differentiation of Residual Disease and Post-radiatio · not yet recruiting
NCT07302074 — Understanding of Rare Inflammatory Arthritis in Comparison to Classical Inflammatory Arthritis : Tissular Observations a · NA · recruiting
NCT06441773 — Impact of Respiratory Rehabilitation on Quality of Life in Patients With Metastatic Non-small Cell Lung Cancer Treated W · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02891876 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Brest
Last refreshed: 29 November 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02891876.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing